A detailed history of Steward Partners Investment Advisory, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 93 shares of MYGN stock, worth $1,440. This represents 0.0% of its overall portfolio holdings.

Number of Shares
93
Previous 35 165.71%
Holding current value
$1,440
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $1,390 - $1,658
58 Added 165.71%
93 $2,000
Q2 2024

Aug 08, 2024

SELL
$17.98 - $25.47 $1,690 - $2,394
-94 Reduced 72.87%
35 $0
Q4 2023

Feb 12, 2024

BUY
$13.91 - $21.32 $1,794 - $2,750
129 New
129 $2,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.25B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.